Literature DB >> 22514277

p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Pierre-Jacques Hamard1, Dana J Lukin, James J Manfredi.   

Abstract

The p53 gene encodes a transcription factor that is composed of several functional domains: the N-terminal transactivation domain, the central sequence-specific DNA binding domain, the tetramerization domain, and the highly basic C-terminal regulatory domain (CTD). The p53 CTD is a nonspecific DNA binding domain that is subject to extensive post-translational modifications. However, the functional significance of the p53 CTD remains unclear. The role of this domain in the regulation of p53 functions is explored by comparing the activity of ectopically expressed wild-type (WT) p53 protein to that of a truncated mutant lacking the 24 terminal amino acids (Δ24). Using quantitative real time PCR and chromatin Immuno-Precipitation experiments, a p53 CTD deletion is shown to alter the p53-dependent induction of a subset of its target genes due to impaired specific DNA binding. Moreover, p53-induced growth arrest and apoptosis both require an intact p53 CTD. These data indicate that the p53 CTD is a positive regulator of p53 tumor suppressor functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514277      PMCID: PMC3381199          DOI: 10.1074/jbc.M111.331298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Authors:  Lijin Feng; Tongxiang Lin; Hiroaki Uranishi; Wei Gu; Yang Xu
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 2.  Lessons from p53 in non-mammalian models.

Authors:  W-J Lu; J M Abrams
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

3.  TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

Authors:  Karim Bensaad; Atsushi Tsuruta; Mary A Selak; M Nieves Calvo Vidal; Katsunori Nakano; Ramon Bartrons; Eyal Gottlieb; Karen H Vousden
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

4.  p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.

Authors:  Yi-Hung Ou; Pei-Han Chung; Te-Ping Sun; Sheau-Yann Shieh
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

5.  p53 isoforms can regulate p53 transcriptional activity.

Authors:  Jean-Christophe Bourdon; Kenneth Fernandes; Fiona Murray-Zmijewski; Geng Liu; Alexandra Diot; Dimitris P Xirodimas; Mark K Saville; David P Lane
Journal:  Genes Dev       Date:  2005-08-30       Impact factor: 11.361

6.  Structural evolution of C-terminal domains in the p53 family.

Authors:  Horng Der Ou; Frank Löhr; Vitali Vogel; Werner Mäntele; Volker Dötsch
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

Review 7.  How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

Authors:  A Olsson; C Manzl; A Strasser; A Villunger
Journal:  Cell Death Differ       Date:  2007-07-13       Impact factor: 15.828

8.  The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.

Authors:  Heather L Armata; David S Garlick; Hayla K Sluss
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

9.  Expression of C-terminal deleted p53 isoforms in neuroblastoma.

Authors:  David Goldschneider; Emilie Horvilleur; Louis-François Plassa; Marine Guillaud-Bataille; Karine Million; Evelyne Wittmer-Dupret; Gisèle Danglot; Hughes de Thé; Jean Bénard; Evelyne May; Sétha Douc-Rasy
Journal:  Nucleic Acids Res       Date:  2006-10-05       Impact factor: 16.971

Review 10.  p53 and its isoforms in cancer.

Authors:  J-C Bourdon
Journal:  Br J Cancer       Date:  2007-07-17       Impact factor: 7.640

View more
  20 in total

1.  p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA-dependent interaction.

Authors:  Huda H Al-Khalaf; Shreeram C Nallar; Dhananjaya V Kalvakolanu; Abdelilah Aboussekhra
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

2.  E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.

Authors:  Luis A Carvajal; Pierre-Jacques Hamard; Crystal Tonnessen; James J Manfredi
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

3.  Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Authors:  J C Senturk; S Bohlman; J J Manfredi
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

4.  Glioma targeting peptide in combination with the P53 C terminus inhibits glioma cell proliferation in vitro.

Authors:  Dan Wang; Meihua Guo; Jiawen Yu; Xinying Wang; Qian Zhang; Xu Yang; Jiaqi Li; Chunhui Zhao; Bin Feng
Journal:  Cytotechnology       Date:  2017-09-06       Impact factor: 2.058

5.  The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.

Authors:  Oleg Laptenko; Idit Shiff; Will Freed-Pastor; Andrew Zupnick; Melissa Mattia; Ella Freulich; Inbal Shamir; Noam Kadouri; Tamar Kahan; James Manfredi; Itamar Simon; Carol Prives
Journal:  Mol Cell       Date:  2015-03-19       Impact factor: 17.970

Review 6.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

7.  Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells.

Authors:  Ramaswamy Kannappan; Saidulu Mattapally; Pooja A Wagle; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

8.  Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.

Authors:  Luis A Carvajal; Daniela Ben Neriah; Adrien Senecal; Lumie Benard; Victor Thiruthuvanathan; Tatyana Yatsenko; Swathi-Rao Narayanagari; Justin C Wheat; Tihomira I Todorova; Kelly Mitchell; Charles Kenworthy; Vincent Guerlavais; D Allen Annis; Boris Bartholdy; Britta Will; Jesus D Anampa; Ioannis Mantzaris; Manuel Aivado; Robert H Singer; Robert A Coleman; Amit Verma; Ulrich Steidl
Journal:  Sci Transl Med       Date:  2018-04-11       Impact factor: 17.956

Review 9.  The multiple mechanisms that regulate p53 activity and cell fate.

Authors:  Antonina Hafner; Martha L Bulyk; Ashwini Jambhekar; Galit Lahav
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

10.  A benchmark for chromatin binding measurements in live cells.

Authors:  Davide Mazza; Alice Abernathy; Nicole Golob; Tatsuya Morisaki; James G McNally
Journal:  Nucleic Acids Res       Date:  2012-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.